These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 29676517)

  • 1. Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis.
    Yu Z; Yang N; Everett BM; Frits M; Iannaccone C; Coblyn J; Weinblatt M; Shadick N; Solomon DH; Liao KP
    Arthritis Rheumatol; 2018 Sep; 70(9):1392-1398. PubMed ID: 29676517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
    Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
    J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of six cardiovascular risk calculators in Mexican mestizo patients with rheumatoid arthritis according to the EULAR 2015/2016 recommendations for cardiovascular risk management.
    Galarza-Delgado DA; Azpiri-Lopez JR; Colunga-Pedraza IJ; Cardenas-de la Garza JA; Vera-Pineda R; Serna-Peña G; Arvizu-Rivera RI; Martinez-Moreno A; Wah-Suarez M; Garza Elizondo MA
    Clin Rheumatol; 2017 Jun; 36(6):1387-1393. PubMed ID: 28150104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis Is Not Superior to the ACC/AHA Risk Calculator.
    Wahlin B; Innala L; Magnusson S; Möller B; Smedby T; Rantapää-Dahlqvist S; Wållberg-Jonsson S
    J Rheumatol; 2019 Feb; 46(2):130-137. PubMed ID: 30275258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of NT-proBNP and high sensitivity C-reactive protein for predicting cardiovascular risk in patients with arthritis taking longterm nonsteroidal antiinflammatory drugs.
    Ruff CT; Morrow DA; Jarolim P; Ren F; Contant CF; Kaur A; Curtis SP; Laine L; Cannon CP; Brune K
    J Rheumatol; 2011 Jun; 38(6):1071-8. PubMed ID: 21459935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discordance of the Framingham cardiovascular risk score and the 2013 American College of Cardiology/American Heart Association risk score in systemic lupus erythematosus and rheumatoid arthritis.
    Jafri K; Ogdie A; Qasim A; Patterson SL; Gianfrancesco M; Izadi Z; Katz P; Yazdany J; Schmajuk G
    Clin Rheumatol; 2018 Feb; 37(2):467-474. PubMed ID: 28993952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of cardiovascular risk in patients with rheumatoid arthritis: do cardiovascular biomarkers offer added predictive ability over established clinical risk scores?
    Finckh A; Courvoisier DS; Pagano S; Bas S; Chevallier-Ruggeri P; Hochstrasser D; Roux-Lombard P; Gabay C; Vuilleumier N
    Arthritis Care Res (Hoboken); 2012 Jun; 64(6):817-25. PubMed ID: 22302385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis.
    Alemao E; Cawston H; Bourhis F; Al M; Rutten-van Molken M; Liao KP; Solomon DH
    Rheumatology (Oxford); 2017 May; 56(5):777-786. PubMed ID: 28087832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Divergence of Cardiovascular Biomarkers of Lipids and Subclinical Myocardial Injury Among Rheumatoid Arthritis Patients With Increased Inflammation.
    Weber B; He Z; Yang N; Playford MP; Weisenfeld D; Iannaccone C; Coblyn J; Weinblatt M; Shadick N; Di Carli M; Mehta NN; Plutzky J; Liao KP
    Arthritis Rheumatol; 2021 Jun; 73(6):970-979. PubMed ID: 33615723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour necrosis factor {alpha} blockade reduces circulating N-terminal pro-brain natriuretic peptide levels in patients with active rheumatoid arthritis: results from a prospective cohort study.
    Peters MJ; Welsh P; McInnes IB; Wolbink G; Dijkmans BA; Sattar N; Nurmohamed MT
    Ann Rheum Dis; 2010 Jul; 69(7):1281-5. PubMed ID: 19934107
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rheumatoid arthritis-specific cardiovascular risk scores are not superior to general risk scores: a validation analysis of patients from seven countries.
    Crowson CS; Gabriel SE; Semb AG; van Riel PLCM; Karpouzas G; Dessein PH; Hitchon C; Pascual-Ramos V; Kitas GD;
    Rheumatology (Oxford); 2017 Jul; 56(7):1102-1110. PubMed ID: 28339992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of vascular function and estimated cardiovascular risk in patients with rheumatoid arthritis.
    Pieringer H; Pohanka E; Puchner R; Brummaier T
    Rev Bras Reumatol Engl Ed; 2017; 57(5):452-460. PubMed ID: 28684239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a carotid-MRI feasibility study.
    Bissell LA; Erhayiem B; Fent G; Hensor EMA; Burska A; Donica H; Plein S; Buch MH; Greenwood JP; Andrews J
    Arthritis Res Ther; 2018 Dec; 20(1):266. PubMed ID: 30509325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [N-terminal pro-brain natriuretic peptide levels and diastolic dysfunction in patients with early rheumatoid arthritis before the administration of disease-modifying antirheumatic drugs].
    Kirillova IG; Novikova DS; Popkova TV; Aleksandrova EN; Novikov AA; Gorbunova YN; Markelova EI; Korsakova YO; Glukhova SI; Volkov AV; Luchikhina EL; Demidova NV; Kasumova KA; Vladimirov SA; Kanonirova MA; Lukina GL; Karateev DE; Nasonov EL
    Ter Arkh; 2016; 88(5):19-26. PubMed ID: 27239922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-6 positively correlates with cardiovascular disease predictor algorithms and biomarker in rheumatoid arthritis patients.
    Roghani SA; Shamsi A; Jalili C; Jalili F; Lotfi R; Garman N; Rostampour R; Taghadosi M
    J Cell Mol Med; 2024 Aug; 28(16):e70028. PubMed ID: 39160453
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The relationship between carotid intima-media thickness and the activity of rheumatoid arthritis.
    Targońska-Stepniak B; Drelich-Zbroja A; Majdan M
    J Clin Rheumatol; 2011 Aug; 17(5):249-55. PubMed ID: 21778898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino-terminal pro-B-type natriuretic peptide and high-sensitivity C-reactive protein but not cystatin C predict cardiovascular events in male patients with peripheral artery disease independently of ambulatory pulse pressure.
    Skoglund PH; Arpegård J; Ostergren J; Svensson P
    Am J Hypertens; 2014 Mar; 27(3):363-71. PubMed ID: 24470529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipid profile and NT-proBNP changes from pre-clinical to established rheumatoid arthritis: A 12 years follow-up explorative study.
    Raadsen R; Dijkshoorn B; van Boheemen L; Ten Boekel E; van Kuijk AWR; Nurmohamed MT
    Joint Bone Spine; 2024 May; 91(3):105683. PubMed ID: 38161051
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis.
    Gonzalez-Gay MA; Gonzalez-Juanatey C; Lopez-Diaz MJ; Piñeiro A; Garcia-Porrua C; Miranda-Filloy JA; Ollier WE; Martin J; Llorca J
    Arthritis Rheum; 2007 Feb; 57(1):125-32. PubMed ID: 17266100
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.
    Arts EE; Popa C; Den Broeder AA; Semb AG; Toms T; Kitas GD; van Riel PL; Fransen J
    Ann Rheum Dis; 2015 Apr; 74(4):668-74. PubMed ID: 24389293
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.